# Clinical and Demographic Features of Patients With Moderate to Severe Active Systemic Lupus Erythematosus in Russia

> **NCT06759519** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 621 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06759519
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-30
- **Primary completion:** 2025-09-19
- **Final completion:** 2025-09-19
- **Target enrollment:** 621 (ACTUAL)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06759519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06759519, "Clinical and Demographic Features of Patients With Moderate to Severe Active Systemic Lupus Erythematosus in Russia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06759519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*